Risorse esterne
Opinione della community
Prezzo Variazione Volume
4 -2.91 €
P/E Obiettivo ad 1anno
0 7.67 €

Compra - Vendi

Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Altri utenti che hanno investito

Transations in last week
Buy: 4
Sell : 2

AngerManagement Genny cash



Trading Watch: Reviewing the Numbers on Shares of Fate Therapeutics, Inc. (NASDAQ:FATE) - Rockville Register

After a recent scan, we have noticed that Fate Therapeutics, Inc. (NASDAQ:FATE) has recently crossed above its 200-day moving average. The stock recently touched the 4.00 price, and was noted trading 12.66% away from the 200-day moving average at ...altro » Leggi

Fate Therapeutics Inc (FATE) Needle Moving -4.13% – The ... - The Business Union

Needle moving action has been spotted in Fate Therapeutics Inc (FATE) as shares are moving today on volatility -4.13% or -0.17 from the open. The NASDAQ ... Leggi

Fate Therapeutics Inc (FATE) Drops Lower Over Past 5 Sessions - Morgan Research

Traders may be relying in part on technical stock analysis. Fate Therapeutics Inc (FATE) currently has a 14-day Commodity Channel Index (CCI) of -72.15. Despite the name, CCI can be used on other investment tools such as stocks. The CCI was designed to ...altro » Leggi

Fate Therapeutics, Inc. (NASDAQ:FATE) Closed Much Higher Than Its 50 Day Moving Average - First News 24

Shares of the company are trading at $3.89 much higher than the 50 day moving average which is $3.43 and which is slightly above the 200 day moving average of $3.73. The 50 day moving average moved up $0.46 and the 200 day average moved up ...altro » Leggi

Fate Therapeutics, Inc. (NASDAQ:FATE) Stock Closed 20.1% Above Its 50 Day Moving Average - Highlight Press

It is currently trading at $4.12 quite a bit above $3.43, the stock's 50 day moving average and significantly above the 200 day moving average of $3.73. The 50 day moving average moved up $0.69 and the 200 day average was up $0.39. Trading was light ...altro » Leggi

Fate Therapeutics, Inc. (FATE): Trading Secrets for Today's Investors - StockNewsGazette

Fate Therapeutics, Inc. (NASDAQ:FATE) gained 8.17% in yesterday's session, going up from its prior closing price of $3.67 to $3.97, and has now recorded rally in 4 consecutive sessions. Many in the market will be closely watching whether this winning ...altro » Leggi

Fmr Llc Now Owns 4346785 Shares In Fate Therapeutics, Inc. (FATE) - Post Analyst

Multiple company employees have indulged in significant insider trading. Fate Therapeutics, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chief Medical Officer Storgard Chris has acquired 37,593 shares of ... Leggi

Are These Stocks Preparing For A Breakout Trade? – Fate Therapeutics, Inc. (FATE), AveXis, Inc. (AVXS) - Post Analyst

Fate Therapeutics, Inc. (NASDAQ:FATE) traded at an unexpectedly low level on 09/18/2017 when the stock experienced a 2.16% gain to a closing price of $4.25. The company saw 0.32 million shares trade hands over the course of the day. Given that its ...altro » Leggi

Investor Toolkit: A look at Fate Therapeutics, Inc. (NasdaqGM:FATE ... - Union Trade Journal

Investors considering positions in Fate Therapeutics, Inc. (NasdaqGM:FATE), might be interested in the Gross Margin Score of the company. The shares ... Leggi

Looking At The Big Picture: Fate Therapeutics, Inc. (FATE), BCE Inc. (BCE) - Post Analyst

Fate Therapeutics, Inc. (NASDAQ:FATE) attracted a lower number of shares in volume with 0.26 million contracts traded on 14-Sep-17. However, its trading capacity stayed around 0.28 million shares in normal days. The first sale was made at $4.34 but ...altro » Leggi